grant
BCG-Mediated Immunotherapy Against Bacteria
NIHUS FederalResearch GrantFY2026AdherenceAdjuvantAgonistAntibiotic AgentsAntibiotic DrugsAntibiotic ResistanceAntibioticsAntigensAttenuatedAttenuated VaccinesBCG LiveBCG VaccineBCG immunotherapyBCG therapyBCG treatmentBacille Calmette Guerin vaccineBacille Calmette-GuérinBacillus Calmette Guerin VaccineBacillus Calmette GuérinBacillus Calmette Guérin immunotherapyBacillus Calmette Guérin therapyBacillus Calmette-Guerin ImmunotherapyBacillus Calmette-Guerin TherapyBacillus Calmette-Guérin vaccineBacteriaBacterial InfectionsBladderBladder CancerBladder Drug AdministrationBladder InstillationsBladder TissueBladder Urinary SystemCell BodyCellsChemicalsClear CellDoseE coliE coli InfectionsE. coliE. coli InfectionsEpithelial CellsEpitheliumEscherichia coliEscherichia coli InfectionsFDA approvedFormulationHost Defense MechanismImmune mediated therapyImmune responseImmunityImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologically Directed TherapyImmunologicsImmunotherapyInfectionInfective cystitisIntravesical AdministrationIntravesical Drug AdministrationIntravesical InstillationLive-attenuated VaccineMTB vaccineMalignant Bladder NeoplasmMalignant CellMalignant Tumor of the BladderMalignant neoplasm of urinary bladderMarrow Mast CellMediatingMedicalMiceMice MammalsMiscellaneous AntibioticMurineMusOccluding JunctionsPatientsPeptidesProbabilityPropertyRecurrenceRecurrentRecurrent NeoplasmRecurrent tumorResearchResistanceResistance to antibioticsResistant to antibioticsResolutionT-CellsT-LymphocyteTB vaccineTh-1 CellTh-2 CellTh1 CellsTh2 CellsTight JunctionsTimeTissue BasophilsTrainingTuberculosis VaccinesType 1 Helper CellType 2 Helper CellUPECUrinary Bladder CancerUrinary Bladder Malignant TumorUrinary tract infectionUrinary tract infectious diseaseUropathogenic E coliUropathogenic E. coliUropathogenic Escherichia coliVaccinatedVaccinationVaccine AntigenVaccine for TBVaccine for TuberculosisZonula Occludensanti-TB vaccineantibiotic drug resistanceantibiotic resistantattenuateattenuatesbacteria infectionbacterial diseasebladder infectioncancer cellcellular targetingcombatcompound optimizationcostcross immunitycross protectiondetermine efficacyefficacy analysisefficacy assessmentefficacy determinationefficacy evaluationefficacy examinationepithelial repairevaluate efficacyexamine efficacyfightingformulation optimizationhost responseimmune system responseimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmunization strategyimmuno therapyimmunogenimmunoresponseinterestintravesicalintravesical BCGlife spanlifespanlive vaccinelive vaccinesmast cellmastocytemastoparanmicrobialneoplasm recurrencenovelpathogenpreventpreventingrecruitrepurposingresistantresolutionssmall moleculestandard of carethymus derived lymphocytetissue repairtumoruptakeurinary bladderurinary infectionvaccination strategyvaccination studyvaccination trialvaccine against M. tuberculosisvaccine against Mtbvaccine against Mycobacterium tuberculosisvaccine against TBvaccine against tuberculosisvaccine candidates against tuberculosisvaccine efficacyvaccine formulationvaccine studyvaccine trial
Description preview
Abstract
Up to 3.5 billion dollars is spent each year, in the US alone, to manage bladder infections and their
recurrence. The intractability of these infections is attributable, in part, to the capacity of bladder bacteria to
persist in the bladder long after infection resolution only to remerge as another flareup. In view of the fact that…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click